نتایج جستجو برای: ifnβ

تعداد نتایج: 404  

Journal: :European journal of neurology 2011
V Devonshire Y Lapierre R Macdonell C Ramo-Tello F Patti P Fontoura L Suchet R Hyde I Balla E M Frohman B C Kieseier

BACKGROUND most disease-modifying therapies (DMTs) for multiple sclerosis (MS) are self-injectable medications that must be taken on an ongoing basis to reduce disease activity. Thus, adherence to therapy becomes an important challenge that must be addressed to maximize benefits of therapy. This study evaluated rates of adherence to prescribed treatment and explored factors affecting adherence ...

2017
Aleksandra Dunislawska Anna Slawinska Katarzyna Stadnicka Marek Bednarczyk Piotr Gulewicz Damian Jozefiak Maria Siwek

Synbiotics are synergistic combinations of prebiotics and probiotics. In chickens, synbiotics can be delivered in ovo to expedite colonization of the gut by beneficial bacteria. We therefore aimed to design synbiotics in vitro and validate them in broiler chickens upon in ovo delivery. The probiotic components of the synbiotics were Lactobacillus salivarius and Lactobacillus plantarum. Their gr...

Journal: :Blood 2016
Weiwei Shen Mrinal M Patnaik Autumn Ruiz Stephen J Russell Kah-Whye Peng

Patients with relapsed acute myeloid leukemia (AML) have limited therapeutic options. Vesicular stomatitis virus (VSV)-interferon β (IFNβ)-sodium iodide symporter (NIS) is an oncolytic VSV encoding IFNβ and the NIS reporter. Syngeneic AML C1498 tumors responded to IV therapy with VSV-murine IFNβ (mIFNβ)-NIS in a dose-dependent manner. Imaging for NIS expression showed robust virus infection wit...

2012
Gabriela Ramírez-Vélez Francisco Medina Luis Ramírez-Montaño Abraham Zarazúa-Lozada Ramiro Hernández Luis Llorente José Moreno

BACKGROUND Overexpression of type I interferon (IFN-I)-induced genes is a common feature of systemic lupus erythematosus (SLE) and its experimental models, but the participation of endogenous overproduction of IFN-I on it is not clear. To explore the possibility that abnormally increased IFN-I receptor (IFNAR) signaling could participate in IFN-I-induced gene overexpression of SLE, we examined ...

Journal: :Therapeutic advances in neurological disorders 2012
Kerstin Hellwig Aiden Haghikia Milena Rockhoff Ralf Gold

OBJECTIVE The objective of this study was to evaluate exposure to disease-modifying therapies (DMTs) during pregnancy in 335 pregnancies of multiple sclerosis (MS) patients and to further determine whether exclusive breastfeeding of MS mothers has any relevant influence on postpartum relapse rate. BACKGROUND Only limited data are available on whether DMT exposure during pregnancy affects rela...

Journal: :Neurology 2012
E Waubant D Pelletier M Mass J A Cohen M Kita A Cross A Bar-Or T Vollmer M Racke O Stüve S Schwid A Goodman N Kachuck J Preiningerova B Weinstock-Guttman P A Calabresi A Miller M Mokhtarani D Iklé S Murphy H Kopetskie L Ding E Rosenberg C Spencer S S Zamvil

OBJECTIVE To test efficacy and safety of atorvastatin in subjects with clinically isolated syndrome (CIS). METHODS Subjects with CIS were enrolled in a phase II, double-blind, placebo-controlled, 14-center randomized trial testing 80 mg atorvastatin on clinical and brain MRI activity. Brain MRIs were performed quarterly. The primary endpoint (PEP) was development of ≥ 3 new T2 lesions, or one...

2016
Sheena L. Dupuy Fariha Khalid Brian C. Healy Sonya Bakshi Mohit Neema Shahamat Tauhid Rohit Bakshi

BACKGROUND Spinal cord atrophy occurs early in multiple sclerosis (MS) and impacts disability. The therapeutic effect of interferon beta-1a (IFNβ-1a) on spinal cord atrophy in patients with relapsing-remitting (RR) MS has not been explored. METHODS We retrospectively identified 16 consecutive patients receiving weekly intramuscular IFNβ-1a for 2 years [baseline age (mean ± SD) 47.7 ± 7.5 year...

Journal: :PloS one 2015
Diego Bertoli Federico Serana Alessandra Sottini Cinzia Cordioli Davide Maimone Maria Pia Amato Diego Centonze Ciro Florio Elisa Puma Ruggero Capra Luisa Imberti

One of the most common adverse event of interferon beta (IFNβ) therapy for multiple sclerosis is flu-like syndrome (FLS), which has been reportedly related to increased levels of cytokines such as interleukin 6 (IL-6) and tumor necrosis factor-alpha (TNF-α). Average cytokine levels can be affected by single nucleotide polymorphism in the gene promoter regions. To investigate whether IL-6 -174 G...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید